When greed meets healthcare - another Scrooge story in the making.

Martin Shkreli, the 32-year-old Turing Pharmaceuticals founder and chief executive who raised eyebrows and a lot of tempers  earlier this year when he upped the price of the AIDS drug Daraprim from $13.50 to $750 per tablet, was arrested in New York city earlier today. Federal agents are charging him with alleged securities fraud related to a previous firm he founded four years ago, Retrophin. Brooklyn prosecutors say he took company cash and stock to pay off debts from unrelated business dealings. The actual indictment, however, remains sealed.